Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.37 USD | -1.76% | +4.61% | -2.18% |
Sep. 06 | Analyst recommendations: Broadcom, Qualcomm, Lululemon Athletica, Vertex Pharmaceuticals... | |
Aug. 16 | UBS Adjusts Price Target on VF to $17 From $12, Maintains Neutral Rating | MT |
Fiscal Period: March | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Net Income | 679M | 408M | 1.39B | 119M | -969M | |||||
Depreciation & Amortization - CF | 249M | 240M | 244M | 240M | 305M | |||||
Amortization of Goodwill and Intangible Assets - (CF) | 18.7M | 17.5M | 15.6M | 14.1M | 13.8M | |||||
Depreciation & Amortization, Total | 268M | 258M | 260M | 254M | 319M | |||||
(Gain) Loss From Sale Of Asset | - | - | - | - | - | |||||
Asset Writedown & Restructuring Costs | 323M | 31.63M | 7.02M | 743M | 508M | |||||
Stock-Based Compensation (CF) | 68.2M | 70.82M | 91.36M | 60.35M | 67.33M | |||||
Provision and Write-off of Bad Debts | 32.93M | 20.67M | -716K | 3.53M | 11.17M | |||||
Net Cash From Discontinued Operations | 74.08M | 79.97M | 6.09M | - | - | |||||
Other Operating Activities, Total | 414M | 324M | 32.3M | 397M | 910M | |||||
Change In Accounts Receivable | -5.95M | 70.47M | -203M | -147M | 325M | |||||
Change In Inventories | -141M | 314M | -381M | -890M | 509M | |||||
Change In Accounts Payable | -73.67M | 20.11M | 105M | 377M | -106M | |||||
Change In Income Taxes | -61.74M | -35.59M | 201M | -1.15B | -155M | |||||
Change in Other Net Operating Assets | -703M | -249M | -642M | -424M | -404M | |||||
Cash from Operations | 875M | 1.31B | 864M | -656M | 1.01B | |||||
Capital Expenditure | -288M | -199M | -245M | -166M | -146M | |||||
Sale of Property, Plant, and Equipment | - | - | - | 99.5M | 26.62M | |||||
Cash Acquisitions | - | -2.01B | 3.76M | - | - | |||||
Divestitures | - | - | 617M | - | - | |||||
Sale (Purchase) of Intangible assets | -45.65M | -75.54M | -82.87M | -95.33M | -65.17M | |||||
Investment in Marketable and Equity Securities, Total | - | -600M | 599M | - | - | |||||
Other Investing Activities, Total | 31.79M | -12.27M | 12.56M | -26.3M | 12.11M | |||||
Cash from Investing | -302M | -2.9B | 904M | -188M | -172M | |||||
Short Term Debt Issued, Total | 577M | - | 324M | - | 255M | |||||
Long-Term Debt Issued, Total | 1.08B | 3B | - | 2.06B | - | |||||
Total Debt Issued | 1.65B | 3B | 324M | 2.06B | 255M | |||||
Short Term Debt Repaid, Total | - | -1.22B | - | -324M | - | |||||
Long-Term Debt Repaid, Total | -649M | -1.66M | -504M | -501M | -908M | |||||
Total Debt Repaid | -649M | -1.22B | -504M | -825M | -908M | |||||
Issuance of Common Stock | 155M | 54.44M | 36.65M | - | - | |||||
Repurchase of Common Stock | -1B | - | -350M | -2.79M | -2.85M | |||||
Common Dividends Paid | -749M | -757M | -773M | -703M | -303M | |||||
Common & Preferred Stock Dividends Paid | -749M | -757M | -773M | -703M | -303M | |||||
Other Financing Activities, Total | 899M | -21.44M | -2.5M | -63.77M | -576K | |||||
Cash from Financing | 310M | 1.05B | -1.27B | 464M | -960M | |||||
Foreign Exchange Rate Adjustments | -27.48M | -30.6M | -73.3M | -80.82M | -22.07M | |||||
Net Change in Cash | 855M | -560M | 426M | -461M | -139M | |||||
Supplemental Items | ||||||||||
Cash Interest Paid | 76.54M | 89.81M | 123M | 160M | 234M | |||||
Cash Income Tax Paid (Refund) | 287M | 188M | 264M | 1.11B | 350M | |||||
Levered Free Cash Flow | 807M | 1.05B | 1.38B | -272M | 805M | |||||
Unlevered Free Cash Flow | 865M | 1.14B | 1.46B | -163M | 958M | |||||
Change In Net Working Capital | -57.44M | -640M | -390M | 873M | -393M | |||||
Net Debt Issued / Repaid | 1B | 1.78B | -180M | 1.23B | -653M |